Create Alert
Watchlist

Auro Laboratories

₹249.25
0.00 (0.00%) 1D
BSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
252.00
Prev. Close
249.25
Volume
1,711
Total traded value
0.04 Cr
Upper Circuit
299.10
Lower Circuit
199.40

Fundamentals

Market Cap₹155Cr
ROE2.42%
P/E Ratio(TTM)147.49
EPS(TTM)1.69
P/B Ratio3.56
Dividend Yield0.00%
Industry P/E40.17
Book Value69.92
Debt to Equity1.01
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Auro Laboratories

Auro Laboratories Limited is a pharmaceutical company that commenced manufacturing activities of Active Pharmaceutical Ingredients (APIs) back in 1992. The company's governance philosophy includes core values of independence, integrity, accountability, and fairness in all its business transactions. It is also committed to enhancing shareholder value in a fair and transparent manner by benchmarking itself against the best global business practices. A key specialty is Metformin Hydrochloride, an oral drug used for managing type 2-diabetes, which the company manufactures as an API. With existing registrations and regulatory approvals, the company has an established customer base in India and various foreign countries for growth. To meet future demand, the company is doubling its Metformin HCL production from 1800 to 3600 metric tons per annum.;
Parent OrganisationAuro Laboratories Limited
Managing DirectorMr. Sharat Deorah
Founded1989
BSE Symbol530233

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
52.18%
Retail And Others
47.82%
Mutual Funds
0.01%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Divi's Laboratories
NA
(0.00%)
68.66
Neuland Laboratories
NA
(0.00%)
85.89
Jubilant Pharmova
NA
(0.00%)
36.43
Acutaas Chemicals
NA
(0.00%)
60.38
2025
12
Nov
Quarterly Result
Release date
14
Aug
Quarterly Result
Release date
30
May
Annual Result
Release date
23
May
Annual Result
Release date
14
Feb
Quarterly Result
Release date
2024
11
Nov
Quarterly Result
Release date
9
Aug
Quarterly Result
Release date
25
May
Result
Release date
Events calendar
View upcoming events in other stocks